BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20424540)

  • 1. Antiplatelet therapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures. Key messages for clinical practice.
    Leontiadis GI; Tse F; Howden CW
    Pol Arch Med Wewn; 2010 Apr; 120(4):143-7. PubMed ID: 20424540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic procedures in patients under clopidogrel/dual antiplatelet therapy: to do or not to do?
    Abdel Samie A; Theilmann L
    J Gastrointestin Liver Dis; 2013 Mar; 22(1):33-6. PubMed ID: 23539388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary stent management in elective genitourinary surgery.
    Gupta AD; Streiff M; Resar J; Schoenberg M
    BJU Int; 2012 Aug; 110(4):480-4. PubMed ID: 22192977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic procedures in patients under clopidogrel or dual antiplatelet therapy: a survey among German gastroenterologists and current guidelines.
    Abdel Samie A; Theilmann L; Labenz J;
    Z Gastroenterol; 2014 May; 52(5):425-8. PubMed ID: 24824906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
    Dai X; Makaryus AN; Makaryus JN; Jauhar R
    Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulation and antiplatelet therapy, and gastrointestinal endoscopy].
    Székely H; Tulassay Z
    Orv Hetil; 2009 Mar; 150(12):541-8. PubMed ID: 19275971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.
    Becker RC; Scheiman J; Dauerman HL; Spencer F; Rao S; Sabatine M; Johnson DA; Chan F; Abraham NS; Quigley EM;
    Am J Gastroenterol; 2009 Dec; 104(12):2903-17. PubMed ID: 19935784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures.
    Becker RC; Scheiman J; Dauerman HL; Spencer F; Rao S; Sabatine M; Johnson DA; Chan F; Abraham NS; Quigley EM; ;
    J Am Coll Cardiol; 2009 Dec; 54(24):2261-76. PubMed ID: 19942393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal bleeding after percutaneous coronary intervention.
    Tanigawa T; Watanabe T; Nadatani Y; Otani K; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
    Digestion; 2011; 83(3):153-60. PubMed ID: 21266809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines.
    Veitch AM; Vanbiervliet G; Gershlick AH; Boustiere C; Baglin TP; Smith LA; Radaelli F; Knight E; Gralnek IM; Hassan C; Dumonceau JM
    Gut; 2016 Mar; 65(3):374-89. PubMed ID: 26873868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on the management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery.
    Franchi F; Rollini F; Angiolillo DJ
    Curr Opin Cardiol; 2014 Nov; 29(6):553-63. PubMed ID: 25144343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy and the risk of bleeding induced by gastrointestinal endoscopic procedures. A systematic review of the literature and recommendations.
    Kimchi NA; Broide E; Scapa E; Birkenfeld S
    Digestion; 2007; 75(1):36-45. PubMed ID: 17429206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.
    Tan VP; Yan BP; Kiernan TJ; Ajani AE
    Cardiovasc Revasc Med; 2009; 10(1):36-44. PubMed ID: 19159853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistaxis as the reason for premature discontinuation of clopidogrel after percutaneous coronary angioplasty with stent implantation.
    Jura-Szołtys E; Chudek J
    Kardiol Pol; 2011; 69(8):817-23. PubMed ID: 21850627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Should platelet inhibitors be discontinued before gastrointestinal endoscopy?].
    Hofstad B; Nesbakken A; Eritsland J; Brørs O; Sandset PM
    Tidsskr Nor Laegeforen; 2008 Nov; 128(21):2440-2. PubMed ID: 19096466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal adverse events after dual antiplatelet therapy: clopidogrel is safer than ticagrelor, but prasugrel data are lacking or inconclusive.
    Serebruany VL; Dinicolantonio JJ; Can MM; Pershukov IV; Kuliczkowski W
    Cardiology; 2013; 126(1):35-40. PubMed ID: 23860246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Should Patients Requiring Dual Antiplatelet Therapy be Managed When Undergoing Elective Endoscopic Gastrointestinal Procedures?
    Sherwood MW; Wang TY; Becker RC
    Curr Treat Options Cardiovasc Med; 2011 Feb; 13(1):46-56. PubMed ID: 21136215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.